Cost-benefit analysis of biomarker-driven early detection of pancreatic cancer in individuals with new-onset diabetes

Irena Stefanova*, Nathan Thompson, Martyn Stott, Lucy Oldfield, Robert Hanson, Robert van der Meer, Daniel Palmer, William Greenhalf, Christopher Halloran, Eithne Costello

*Corresponding author for this work

Research output: Contribution to conferencePosterpeer-review

5 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cost-benefit analysis of biomarker-driven early detection of pancreatic cancer in individuals with new-onset diabetes'. Together they form a unique fingerprint.

Medicine and Dentistry